Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04223726

Chronic Arterial Disease, Quality of Life and Mortality in Chronic Kidney Injury

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
210 (actual)
Sponsor
Turku University Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

CADKID-study is a prospective follow-up study assessing arterial disease, quality of life, mortality and their predictors in patients with severe chronic kidney disease.

Detailed description

Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease and mortality as well as impaired quality of life. Participants of this study all have severe CKD, defined as estimated glomerular filtration rate \< 30 ml/min per 1.73 m\^2. Stress ergometry, echocardiography, ultrasound assessment of arterial intima-media thickness, lateral lumbar radiograph, ECG, laboratory tests and quality of life assessment were performed at the baseline of the study and will be repeated during follow-up. Atrial fibrillation and other cardiac arrhythmias as well as pulse wave velocity measurements will be explored. Diet diaries are gathered and analysed. The aim of the study is to identify factors associated with cardiovascular disease, quality of life and mortality in this cohort.

Conditions

Timeline

Start date
2013-08-22
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2020-01-10
Last updated
2024-04-25

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT04223726. Inclusion in this directory is not an endorsement.